Beijing Yimiao Shenzhou Pharmaceutical Technology
PrivateLast Round
Series G
Jan 8, 2025
Est. Valuation
$530.5M
Total Funding Raised
$173.28M
Company Overview
Beijing Yimiao Shenzhou Pharmaceutical Technology is a clinical-stage biopharmaceutical company that develops CAR-T cell therapies and gene-based medicines for the treatment of cancer and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Yimiao Shenzhou Pharmaceutical Technology Comparables
Compare Beijing Yimiao Shenzhou Pharmaceutical Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hrain Biotechnology Co., Ltd. | 90% | |
| Juventas Cell Therapy Ltd. | 89% | |
| IASO Bio | 88% | |
Beijing Yimiao Shenzhou Pharmaceutical Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series G | Jan 8, 2025 | ||||
| Private Equity | May 1, 2023 | ||||
| Series D Extension | Oct 31, 2022 | ||||
| Series D | Nov 24, 2021 | ||||
| Series C Extension | Dec 22, 2020 | ||||
Series C Extension | Oct 16, 2020 |
Beijing Yimiao Shenzhou Pharmaceutical Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| China Development Bank Capital | Series G |
| GF Qianhe Investment | Series D |
| Thiel Capital | Series B, Series A |
| Legend Capital | Series B |
| Beijing Zhongguancun Science City Innovation Development Co., Ltd. | Series D Extension |
| 北京首都科技发展集团有限公司 | Series A |
| SDIC Venture Capital | Series C Extension, Series D, Series G |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 31, 2022
$28M round led by Beijing Zhongguancun Science City Innovation Development Co., Ltd.
- Nov 24, 2021
$47M round led by China Life Healthcare Fund.
Beijing Yimiao Shenzhou Pharmaceutical Technology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beijing Yimiao Shenzhou Pharmaceutical Technology's valuation, stock price, and market status.